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Mechanisms of streptomycin resistance: selection of mutations in
the 16S rRNA gene conferring resistance
Abstract
Chromosomally acquired streptomycin resistance is frequently due to mutations in the gene encoding
the ribosomal protein S12, rpsL. The presence of several rRNA operons (rrn) and a single rpsL gene in
most bacterial genomes prohibits the isolation of streptomycin-resistant mutants in which resistance is
mediated by mutations in the 16S rRNA gene (rrs). Three strains were constructed in this investigation:
Mycobacterium smegmatis rrnB, M. smegmatis rpsL(3+), and M. smegmatis rrnB rpsL(3+). M.
smegmatis rrnB carries a single functional rrn operon, i.e., rrnA (comprised of 16S, 23S, and 5S rRNA
genes) and a single rpsL+ gene; M. smegmatis rpsL(3+) is characterized by the presence of two rrn
operons (rrnA and rrnB) and three rpsL+ genes; and M. smegmatis rrnB rpsL(3+) carries a single
functional rrn operon (rrnA) and three rpsL+ genes. By genetically altering the number of rpsL and rrs
alleles in the bacterial genome, mutations in rrs conferring streptomycin resistance could be selected, as
revealed by analysis of streptomycin-resistant derivatives of M. smegmatis rrnB rpsL(3+). Besides
mutations well known to confer streptomycin resistance, novel streptomycin resistance conferring
mutations were isolated. Most of the mutations were found to map to a functional pseudoknot structure
within the 530 loop region of the 16S rRNA. One of the mutations observed, i.e., 524G-->C, severely
distorts the interaction between nucleotides 524G and 507C, a Watson-Crick interaction which has been
thought to be essential for ribosome function. The use of the single rRNA allelic M. smegmatis strain
should help to elucidate the principles of ribosome-drug interactions.
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Chromosomally acquired streptomycin resistance is frequently due to mutations in the gene encoding the
ribosomal protein S12, rpsL. The presence of several rRNA operons (rrn) and a single rpsL gene in most
bacterial genomes prohibits the isolation of streptomycin-resistant mutants in which resistance is mediated by
mutations in the 16S rRNA gene (rrs). Three strains were constructed in this investigation: Mycobacterium
smegmatis rrnB, M. smegmatis rpsL3, and M. smegmatis rrnB rpsL3. M. smegmatis rrnB carries a single
functional rrn operon, i.e., rrnA (comprised of 16S, 23S, and 5S rRNA genes) and a single rpsL gene;
M. smegmatis rpsL3 is characterized by the presence of two rrn operons (rrnA and rrnB) and three rpsL genes;
and M. smegmatis rrnB rpsL3 carries a single functional rrn operon (rrnA) and three rpsL genes. By genet-
ically altering the number of rpsL and rrs alleles in the bacterial genome, mutations in rrs conferring
streptomycin resistance could be selected, as revealed by analysis of streptomycin-resistant derivatives of
M. smegmatis rrnB rpsL3. Besides mutations well known to confer streptomycin resistance, novel streptomycin
resistance conferring mutations were isolated. Most of the mutations were found to map to a functional pseu-
doknot structure within the 530 loop region of the 16S rRNA. One of the mutations observed, i.e., 524G3C,
severely distorts the interaction between nucleotides 524G and 507C, a Watson-Crick interaction which has
been thought to be essential for ribosome function. The use of the single rRNA allelic M. smegmatis strain
should help to elucidate the principles of ribosome-drug interactions.
Many antibiotics inhibit the growth of bacteria by targeting
protein biosynthesis (3, 7, 34). Streptomycin, an aminocyclitol
aminoglycoside, has been shown to interact directly with the
small ribosomal subunit (8, 24). The ribosome accuracy center
is a highly conserved component of the translational apparatus
(1), comprising an rRNA domain and several polypeptides of
the small subunit, including the ribosomal protein S12 (8, 29).
A number of mutations in the rpsL gene encoding the S12 poly-
peptide generate resistance to streptomycin (10, 36, 46, 47, 49).
Rather than being a mere scaffold for ribosomal proteins,
the rRNA has important functions and is a main target for
drugs interfering with bacterial protein synthesis (12, 26, 33,
42). Mutations within rRNA genes have been found to confer
drug resistance; for some of these mutations experimental
proof for a cause-effect relationship has been provided (9, 21,
40, 50). More recently, mutations in rRNA genes have been
found to be associated with in vivo acquired drug resistance in
bacterial pathogens, e.g., in Mycobacterium tuberculosis resis-
tant to streptomycin (10); most of the mutations found mapped
to the 530 region of 16S rRNA (15, 27). This unique mecha-
nism of acquired resistance due to mutational rRNA alter-
ations has been attributed to the presence of a single rrn
operon in this pathogen (7).
The 530 loop region is one of the most highly conserved 16S
rRNA regions both in sequence and in secondary structure
(13). The 530 loop region is part of the aminoacyl-tRNA bind-
ing site (A-site) and is involved in the decoding process (8, 25).
Several lines of evidence indicate that the universally con-
served 530 loop of 16S rRNA—in particular a pseudoknot
structure formed by residues 526-CCG-524 and 505-GGC-
507—plays a crucial role in translation, with mild perturbations
of this structure, e.g., creation of G-U wobble base pairs, gen-
erating resistance to and reducing affinity for streptomycin
(31). Data from in vitro assembly studies suggest that the
pseudoknot structure is stabilized by ribosomal protein S12,
which protects these bases from attack by kethoxal and di-
methyl sulfate (44). The specificity of these probes for N1 and
N2 of guanine and N3 of cytosine provided direct evidence for
a Watson-Crick pairing, rather than some alternative mode of
base pair interaction.
During the past years tremendous progress has been made
in the analysis of ribosomes and most recently their structure
has been resolved at an atomic resolution (4, 28, 39, 48). The
crystal structure of the 30S subunit complexed with streptomy-
cin (8) identified the 16S rRNA nucleotides directly involved
in drug binding. However, streptomycin resistance-associated
mutations have not only been observed in nucleotides directly
involved in drug binding (10, 15, 16, 27). In addition, transla-
tion is a highly dynamic process which requires alterations in
base pairing resulting in conformational changes (20). Thus,
besides crystallographic analyses, additional investigations in-
cluding chemical, biochemical, and genetic methods will be
necessary to elucidate the mechanisms of antibiotic action.
M. tuberculosis is a pathogenic microorganism which grows
very slowly (generation time, 20 to 24 h) and is hardly amena-
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ble to genetic manipulations. The lack of a eubacterium suit-
able for genetic manipulations, which allows the isolation of in
vivo selection-driven mutational rrs alterations conferring re-
sistance to streptomycin, severely hampers our understanding
of structure-function relationship within rRNAs. The presence
of a limited number of rRNA operons, its apathogenic nature,
the high growth rate, and the ability for genetic manipulations
make Mycobacterium smegmatis an ideal host for the investi-
gation of eubacterial rRNA structure-function relationships
(32, 37, 38). More recently, functional inactivation of the Esch-
erichia coli rrn operons has been used to generate strains with
a single rRNA operon (2).
To learn more about (i) mechanisms of streptomycin resis-
tance in general, (ii) structure-function relationships in rRNA,
in particular 16S rRNA-mediated streptomycin resistance, and
(iii) dominance-recessivity relationships of ribosomal resis-
tance mechanisms, M. smegmatis strains with different copy
numbers of genes encoding the targets of streptomycin, i.e.,
rpsL and rrs, were generated. Strains were constructed to al-
low selection of streptomycin resistance-conferring mutations
to appear exclusively in rrs. Drug resistance mutations were
mapped in rrs, and by allele exchange techniques a cause-effect
relationship of the mutations observed was demonstrated. We
made the surprising finding that a base pair interaction thought
to be required for proper ribosome function is severely affected
by one of the most frequently identified mutations.
MATERIALS AND METHODS
DNA manipulations. Standard methods were used for restriction endonucle-
ase digestion of DNA, hybridization analysis, and other manipulations (35).
Plasmid DNA was isolated by the alkaline lysis method (5) or by using the
Qiagen plasmid DNA preparation kit according to the manufacturer’s instruc-
tions. All initial cloning procedures were performed with E. coli XL-1 Blue
MRF (Stratagene). Transformants were grown in Luria-Bertani (LB) medium
containing ampicillin (100 g/ml) or kanamycin (50 g/ml). Ampicillin, kanamy-
cin, gentamicin, and hygromycin were obtained from Sigma; clarithromycin was
a generous gift from Abbott GmbH (Wiesbaden).
DNA probes for Southern blot hybridization were labeled with digoxigenin
according to the manufacturer’s instructions (Boehringer Mannheim).
Strains and plasmids. The strains and plasmids used in this study are listed in
Table 1. Plasmid prRNA::aph-sacB was constructed by digestion of plasmid
prRNA4-4K1 with SalI and ligation to a 2-kbp sacB gene fragment (EcoRV/
BamHI) from plasmid pLO2 (19).
16S rRNA gene fragments carrying mutations rrs523A3C, rrs524G3C, and
rrs526C3T were obtained by PCR amplification using DNA isolated from spon-
taneous streptomycin-resistant M. smegmatis strains carrying the corresponding
mutation. PCR amplification was performed with primers #285 and #251 (Table
2). PCR products were subcloned into the pGEM-T vector (Promega). A 600-bp
XhoI/EcoRV fragment containing the 530 loop region was isolated and used to
replace the homologous gene fragment in plasmid pMV361-H-rRNA2058G,
which previously was digested to completion with EcoRV and partially digested
with XhoI. Plasmid pMV361-H-rRNA2058G expresses a functional rrnB operon
under control of its own promoter. Sequencing with primers #242 and #259
confirmed that only the desired mutation was present. Resulting plasmids were
pMV361-H-rRNA523C/2058G, pMV361-H-rRNA524C/2058G, and pMV361-
H-rRNA526T/2058G, respectively.
Transformation of mycobacteria. Mycobacteria were made electrocompetent
essentially as described previously (36). This method is a modification of the
method described by Jacobs et al. (17). In short, M. smegmatis strains were grown
until an optical density at 600 nm of 0.4 to 0.6 was achieved, and cells were
incubated on ice for 1.5 h. The cells were then collected by centrifugation,
washed several times with ice-cold glycerol (10%, vol/vol), and finally were
resuspended in a 1/500 volume of glycerol (10%). Cells (100 l) were mixed with
1 g of plasmid DNA. Electroporation was performed in 0.2-cm cuvettes with a
single pulse (2.5 kV, 25 F, 1,000 ) in a Bio-Rad gene pulser. Cells were
immediately resuspended in 1 ml of brain heart infusion medium and incubated
for 2 h with vigorous shaking at 37°C. Afterwards serial dilutions were plated.
When appropriate, antibiotics or sucrose was added at the following concentra-
tions: kanamycin, hygromycin, or clarithromycin, 50 g/ml; gentamicin, 15 g/ml;
sucrose, 7.5% (wt/vol).
TABLE 1. Strains and plasmids used in the study
Strain or plasmid Source orreference Description
Strains
E. coli XL-1 Blue MRF Stratagene
M. smegmatis mc2 155 41 Two functional rrn
operons, one rpsL
M. smegmatis rpsL3 This study Two functional rrn
operons, three rpsL
M. smegmatis rrnB This study One functional rrn
operon, one rpsL
M. smegmatis rrnB rpsL3 This study One functional rrn
operon, three rpsL
Plasmids
prRNA4-4K1 36
pGEM-T vector Promega
pLO2 19
pHRM3-Gma 11
pMV361-H-rRNA2058G 38
prRNA::aph-sacBb This study
pMV361-H-rRNA523C/2058Gc This study
pMV361-H-rRNA524C/2058Gc This study
pMV361-H-rRNA526T/2058Gc This study
a pyrF targeting vector.
b Targeting vector for inactivation of rrnB.
c Integrating vector with mutated rrn operon.
TABLE 2. Primers used in the study
Primer Sequence Source Gene or phageamplified Position
a
#11 GTCGAGGTCACGGCGTAC M. tuberculosis rpsL 181–198
#211 CCCACCATTCAGCAGCTGGT Mycobacteria rpsL
#212 GTCGAGCGAACCGCGAATGA Mycobacteria rpsL
#242 CTACGGGAGGCAGCAGTGGG M. smegmatis rrs 340–359
#251 GGCATCGCAGCCCTTTGTAC M. smegmatis rrs 1,256–1,237
#259 TTTCACGAACAACGCGACAA M. smegmatis rrs 599–580
#261 AAGGAGGTGATCCAGCCGCA M. smegmatis rrs 1,539–1,520
#264 TGCACACAGGCCACAAGGGA M. smegmatis rrs 1,072–1,052
#285 GAGAGTTTGATCCTGGCTCAG M. smegmatis rrs 9–29
#612 GTAATACGACTCACTATAGGGC pHRM3-GM T7 625–646
#651 AATTAACCCTCACTAAAGGG pHRM3-GM T3 2,890–2,871
a E. coli numbering. The positions of primers #211 and #212 can be found in reference 15.
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Mapping of streptomycin resistance-conferring mutations. Spontaneous
streptomycin-resistant mutants were generated by spreading 1  108 to 5  109
bacteria on brain heart infusion agar plates containing streptomycin at a con-
centration of 20 g/ml; in parallel, dilutions of the bacterial suspension were
plated on antibiotic-free medium. The frequency of resistance mutations was
calculated by dividing the number of CFU on selective medium by the number
of CFU on nonselective medium. An approximation of the mutational rate is
given as the median of at least five independent experiments. MICs of strepto-
mycin were determined by spreading mutants on agar plates containing 20, 100,
and 200 g of streptomycin/ml. Incubation time was between 3 and 5 days.
For nucleic acid extraction, a small loop of bacteria was dispersed in 100 l of
H2O and heated for 10 min at 80°C. After addition of glass beads (100-m
diameter; Sigma) a tissue disintegrator (H. Mickle) was used to disrupt the cells.
Following centrifugation the supernatant was transferred to a fresh microcen-
trifuge tube, and 5 l was used as template for amplification PCRs.
Primers #211 and #212 (15) (see Table 2) were used to amplify rpsL, and
primers #285 and #261 were used for amplification of rrs. Sequencing of rpsL
was performed with #211; sequencing of rrs was performed with primers #242,
#259, #261, #264, and #285. Primer #11 in combination with primer #612 or
#651 was used to confirm transformation with plasmid pHRM3-Gm. An ABI
373 sequencer was used for sequence determination.
RecA-mediated gene conversion. To obtain strains which had undergone ho-
mologous recombination, clones obtained by transformation with vectors
pMV361-H-rRNA523C/2058G, pMV361-H-rRNA524C/2058G, and pMV361-
H-rRNA526T/2058G were grown in liquid broth, and serial dilutions were plated
on LB agar containing streptomycin at a concentration of 20 g/ml. The fre-
quency of streptomycin-resistant recombinants was calculated by dividing the
number of CFU obtained on agar plates containing streptomycin by the number
of CFU obtained on nonselective medium.
Transformants were analyzed by manual DNA sequencing of the 16S ribo-
somal DNA (rDNA) PCR products (see above) using 32P-labeled dCTP, se-
quenase (U.S. Biochemicals), and primer #259 to investigate their genotype
(homogeneous or heterogeneous).
RESULTS
Generation of strains. The genome of M. smegmatis carries
two rrn operons (rrnA and rrnB) and a single rpsL gene. Ge-
netic engineering techniques were used to generate strains of
M. smegmatis with different copy numbers of the main strep-
tomycin target genes. The strains and plasmids used are shown
in Table 1. prRNA::aph-sacB carries an inactivated rrnB oper-
on from M. smegmatis, including the promoter region, the 5
part of rrs, the 3 part of rrl, and the entire rrf. An aph cassette
cloned between the partially deleted rrs and rrl confers resis-
tance to kanamycin; the inactivated rrn operon was cloned
proximal to a sacB cassette. sacB facilitates the isolation of
FIG. 1. Southern blot analysis (A) and schematic drawing (B) of
the rrn loci. Lane 1, M. smegmatis mc2 155; lane 2, M. smegmatis mc2
155 rpsL3; lane 3, M. smegmatis rrnB (#1432); lane 4, M. smegmatis
rrnB (#1434). Approximately 200 ng of genomic DNA was digested to
completion with SmaI and hybridized to a 5 probe of the M. smegmatis
16S rRNA gene (16S rRNA positions 5 to 788). Hybridization was
performed under stringent conditions. The lower band corresponds to
the rrnA operon, and the upper band corresponds to the rrnB operon.
A shift of the upper band indicates functional inactivation of the rrnB
operon. wt, wild type; M, molecular size standards.
FIG. 2. Southern blot analysis (A) and schematic drawing (B) of
the pyrF locus. Lane 1, M. smegmatis mc2 155; lane 2, M. smegmatis
rrnB; lane 3, M. smegmatis rpsL3; lane 4, M. smegmatis rrnB rpsL3;
lane 5, streptomycin-resistant mutant (rrs524C) of M. smegmatis rrnB
rpsL3. M, molecular size standard. Approximately 200 ng of genomic
DNA was digested to completion with MluI and hybridized to a 1-kb
SacI fragment of the pyrF gene. Additional recognition sites are given
for better orientation. Integration of vector pHRM3-Gm at the pyrF
locus by a single crossover (sco) is indicated by a shift of the hybrid-
izing fragment. wt, wild type.
VOL. 45, 2001 16S rRNA MUTATIONS 2879
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allelic replacement mutants, as it confers sensitivity towards
sucrose in mycobacteria (30).
Following transformation with prRNA::aph-sacB, clones re-
sistant to kanamycin and sucrose were characterized geneti-
cally. Investigation by PCR and Southern blot analysis (Fig. 1)
demonstrated inactivation of the rrnB operon in two of seven
strains analyzed (M. smegmatis rrnB strains 1432 and 1434).
We next wanted to integrate additional rpsL alleles into the
genome of M. smegmatis. Previous investigations have revealed
that the integrative vector pMV361 is unstable under negative
selective pressure and is frequently lost from the genome (43).
To ensure that the introduced rpsL alleles are stably main-
tained, they were integrated into a specific chromosomal po-
sition using a targeting vector. Strains M. smegmatis rrnB 1432
and 1434 as well as the parental strain M. smegmatis mc2 155
(41) were transformed with plasmid pHRM3-Gm, a derivative
of the suicide vector pHRM3, which targets pyrF (11). The
coding region of pyrF is interrupted by a gentamicin resistance
marker gene. Each side of the pyrF gene (5 and 3 regions) is
flanked by a wild-type rpsL gene from Mycobacterium bovis
BCG. Transformants were selected on uracil-free medium (to
ensure a single crossover at the pyrF, thereby retaining a func-
tional pyrF allele) in the presence of gentamicin. The presence
of two additional M. bovis BCG rpsL wild-type genes in the
transformants was confirmed by PCR analysis (data not
shown). Southern blot analysis demonstrated that plasmid
pHRM3-Gm had integrated at the genomic pyrF locus by ho-
mologous recombination (Fig. 2).
After transformation, strains with the following genotypes
were generated: (i) M. smegmatis rrnB (strain with a single
functional rrn operon and a single rpsL gene), (ii) M. smeg-
matis rpsL3 (rrn wild-type strain with three rpsL genes), and
(iii) M. smegmatis rrnB rpsL3 (single rrn allelic strain with
three rpsL genes [Table 3]).
Isolation of streptomycin-resistant mutants. To select for
streptomycin-resistant mutants, strains M. smegmatis mc2 155,
M. smegmatis rrnB, M. smegmatis rpsL3, and M. smegmatis
rrnB rpsL3 were plated on agar containing streptomycin at a
concentration of 20 g/ml. Mutants were readily obtained for
strains containing either a single rpsL gene (M. smegmatis
mc2 155, M. smegmatis rrnB) or a single functional rRNA
operon (M. smegmatis rrnB rpsL3). No streptomycin-resistant
mutants could be isolated from M. smegmatis carrying two rrn
operons and three rpsL genes (M. smegmatis rpsL3). The
mutation frequencies determined are given in Table 3.
Characterization of spontaneous streptomycin-resistant
strains. To locate the genetic alterations associated with strep-
tomycin resistance, sequence analysis of rpsL and rrs genes was
performed. Investigation of 20 streptomycin-resistant deriva-
tives of M. smegmatis mc2 155 identified rpsL mutations in each
of these mutants. Mutations were restricted to codons 42 and
87. Changes in codon 42 resulted in the replacement of Lys by
Arg, Thr, Asn, or Met; changes in codon 87 resulted in the
replacement of Lys by Glu or Arg. The streptomycin-resistant
derivatives of the single rrn allelic strain M. smegmatis rrnB also
revealed an altered rpsL sequence (four of four investigated;
see Table 4). Sequence analysis of the single functional rrs gene
in streptomycin-resistant derivatives of M. smegmatis rrnB
rpsL3 demonstrated alterations in the 530 loop region in all
mutants (22 of 22 investigated; see Table 4) (Fig. 3). The
frequency with which mutants appeared on the selection plate
corresponds to the frequency of single point mutations in
M. smegmatis rDNA (108 to 1010 [37, 38]). The most fre-
quent mutation (found in 12 out of 22 sequences) observed was
a G3C transversion at position 524 (E. coli numbering). A
mutation at this position previously has not been associated
with resistance to streptomycin. The other prominent mutation
was a 526 C3T transition (found in 7 out of 22 sequences).
Two mutants exhibited a C3T transition at position 522, and
a single resistant strain showed a 523A3C transversion. No
mutations were found in rrs nucleotides directly interacting
with streptomycin (e.g., G527, A913, and A914). However, the
possibility that additional mutants, e.g., in the 912 region (15),
might be isolated when screening a larger number of mutants
cannot be excluded.
The MICs determined (Table 5) showed high levels of strep-
tomycin resistance for rpsL mutant strains and for rrs mutation
524G3C (200 g/ml). rrs mutations 526C3T, 522 C3T,
and 523 A3C conferred an intermediate level of resistance
(100 g/ml). Strains carrying the mutation rrs524G3C grew
poorly in the absence of streptomycin; growth was restored in
the presence of streptomycin, indicating that rrs524C confers a
streptomycin-dependent phenotype.
Introduction of sensitive and resistant rrs alleles into wild-
type and mutant strains. To demonstrate that the observed
streptomycin-resistant phenotype in strains carrying rrs muta-
tions maps to the small subunit rRNA and to exclude other
unknown mutations, transformations with vector pMV361-
H-rRNA2058G (38) were carried out in strains carrying mu-
TABLE 3. Frequency of streptomycin-resistant mutants of M. smegmatis strains carrying different numbers of functional rrn and rpsL genes
Strain No. of rrn operons No. of rpsL genes Median mutation frequencya Mutation frequency range
M. smegmatis mc2 155 (wild type) 2 1 1.3  108 6.6  108–1.5  109
M. smegmatis rpsL3 2 3 2  1012
M. smegmatis rrnB 1 1 6.6  109 2.1  108–1.3  109
M. smegmatis rrnB rpsL3 1 3 4.4  1010 1.3  108–2.0  1010
a Median from at least five experiments.
TABLE 4. Streptomycin resistance-associated mutations
Mutated gene or
nucleotide change
M. smegmatis strain investigated
(no. of altered sequences/total no. investigated)
mc2 155 rrnB rrnB rpsL3
rpsL 20/20 4/4 0/22
rrs 0/20 0/4 22/22
522C3T 2/22
523A3C 1/22
524G3C 12/22
526C3T 7/22
2880 SPRINGER ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 at UNIVERSITATSSPITAL on M
arch 27, 2009 
a
a
c.a
sm
.o
rg
D
ow
nloaded from
 
tations rrs523C, rrs524C, and rrs526T. pMV361 is a vector that
integrates once into the mycobacterial genome at the attB site
(45). pMV361-H-rRNA2058G contains a hygromycin resis-
tance gene and the entire rrnB operon from M. smegmatis. An
A3G transition at position 2058 in the 23S rRNA gene con-
fers resistance to clarithromycin (resistant phenotype is dom-
inant [38]), allowing phenotypic characterization of the plas-
mid-carried rRNA operon. Given that streptomycin resistance-
conferring mutations are recessive in a merodiploid strain (18),
we reasoned that transfection with a wild-type rrs allele should
render the strains with a streptomycin resistance-conferring
mutation in rrs sensitive to this drug. Following selection on
hygromycin, the transformants were plated on streptomycin- or
clarithromycin-containing agar. While transformants exhibited
a clarithromycin-resistant phenotype, plating on streptomycin
demonstrated that upon transformation with the rrn-2058G
operon a streptomycin-sensitive phenotype was restored (see
Table 5). These results indicate that the resistant phenotype
maps to rrn.
RecA-mediated gene conversion (32) was used to experi-
mentally verify that the 16S rRNA mutations observed confer
a resistant phenotype and to exclude the possibility of com-
pensatory mutations. Site-directed mutations were introduced
into plasmid pMV361-H-rRNA2058G, resulting in plasmids
pMV361-H-rRNA523C/2058G, pMV361-H-rRNA524C/2058G,
and pMV361-H-rRNA526T/2058G. The plasmids were subse-
quently transformed into the single rrn allelic strain M. smeg-
matis rrnB. Following selection on hygromycin to ensure inte-
gration of the vector, the cells were plated on hygromycin plus
streptomycin to select for RecA-mediated gene conversion of
the mutant allele (32). Streptomycin-resistant transformants
were obtained with a frequency of 105 to 106. This fre-
quency is several orders of magnitude higher than the fre-
quency of spontaneous resistance (108 to 1010).
Using PCR-mediated sequence analysis, the 16S rRNA gene
of streptomycin-resistant mutants was analyzed. In transfor-
mants grown in the presence of streptomycin, a homogeneous
mutant genotype was observed at the mutated 16S rRNA po-
sition introduced, i.e., positions 523, 524, and 526 (Fig. 4).
These transformants originate from RecA-mediated homolo-
gous recombination between the vector-derived rrn operon and
TABLE 5. Streptomycin MICs for rpsL and rrs mutant strains
Strain MIC (g/ml)
Parental strains
M. smegmatis mc2 155 ............................................................ 20
M. smegmatis rpsL3 .............................................................. 20
M. smegmatis rrnB .................................................................. 20
M. smegmatis rrnB rpsL3...................................................... 20
rpsL mutant strains
rpsL42Lys3Arg ...................................................................... 200
rpsL42Lys3Asn ...................................................................... 200
rpsL42Lys3Thr ...................................................................... 200
rpsL42Lys3Met...................................................................... 200
rpsL88Lys3Glu ...................................................................... 200
rpsL88Lys3Arg ...................................................................... 200
rrs mutant strains
rrs524G3C.............................................................................. 200
rrs526C3T............................................................................... 20–100
rrs522C3T............................................................................... 20–100
rrs523A3C .............................................................................. 20–100
rrs mutant strains transformed with rrs wild-type gene
rrs524G3C::pMV361-H-rRNA2058G................................. 20
rrs526C3T::pMV361-H-rRNA2058G ................................. 20
rrs523A3C::pMV361-H-rRNA2058G ................................. 20
rrnB knockout strain transformed with different rrs
allelesa
pMV361-H-rRNA2058b,c ....................................................... 20
pMV361-H-rRNA524C2058Gb ............................................. 200
pMV361-H-rRNA526T2058Gb ............................................. 20–100
pMV361-H-rRNA523C2058Gc ............................................. 20–100
a Mutants were tested after selection on medium containing hygromycin
(50 g/ml) plus streptomycin (20 g/ml).
b Strain rrnB was transformed.
c Strain rrnB rpsL3 was transformed.
FIG. 3. Secondary structure of the 530 loop region. rrs mutations
associated with streptomycin resistance and isolated in this study are
indicated by an arrow. Nucleotides involved in tertiary structure inter-
action resulting in pseudoknots are shown in gray and are connected by
dotted lines.
FIG. 4. 16S rDNA sequence of the 530 loop region. The wild-type
sequence of a single rRNA allelic strain (A) is shown along with
the same region of transformants obtained with plasmids pMV361-
H-rRNA523C/2058G (B), pMV361-H-rRNA524C/2058G (C), and
pMV361-H-rRNA526T/2058G (D) after selection on streptomycin.
The mutated nucleotide is indicated by an asterisk.
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the single functional chromosomal rrn operon resulting in gene
conversion of the mutant allele.
Physiological investigations demonstrated that streptomycin
MIC levels for the strains with RecA-mediated homogeneous
mutant rRNA alleles were identical to those for the spontane-
ous resistant mutants with the corresponding mutation (see
Table 5). In particular, introduction of mutation rrs524C re-
sulted in a streptomycin-dependent phenotype.
DISCUSSION
Ribosomal protein S12 (RpsL) and the small subunit rRNA
are the main targets of streptomycin-mediated translational
inhibition. By altering the number of genes expressing sensitive
alleles in M. smegmatis, we have generated strains of eubacte-
ria which allow a detailed investigation of the mechanisms
underlying streptomycin resistance. Our results seem to be
somewhat in contrast to those of a previous report, where
mutations in rpsD of Salmonella enterica serovar Typhimurium
have been postulated to confer streptomycin resistance. How-
ever, it should be noted that these mutations were isolated by
selecting for chromosomal alterations, which would compen-
sate for streptomycin-dependent rpsL alleles, rather than by
selecting for streptomycin resistance itself (6). Although we
cannot exclude the theoretical possibility that some rare mu-
tations outside rrs and rpsL may cause primary ribosomal re-
sistance to streptomycin and were missed in our selection pro-
cedure, we consider this possibility highly unlikely, as (i) a low
drug concentration (20 g/ml) was used in the selection pro-
cedure, and (ii) no resistant mutants were isolated from
M. smegmatis carrying two rrs genes and three rpsL genes. Our
data are supported by recent structural analyses of the 30S
ribosomal subunit demonstrating that the streptomycin bind-
ing site is composed of defined rrs nucleotides and stabilized by
the RpsL protein (8).
These data suggest that strain M. smegmatis rrnB rpsL3 can
only become streptomycin resistant by mutations in a rRNA
gene. We have isolated resistant strains covering a total of four
different mutations. All streptomycin-resistant mutants iso-
lated in these experiments show a single point mutation in a
small region of the 16S rRNA.
The frequency of appearance of resistant rRNA mutants
(1010) falls within the mutation frequency of M. smegmatis,
strongly suggesting that no second-site mutations (for example,
in ribosomal protein genes) contributed to resistance. This
conclusion was further corroborated by introducing the respec-
tive mutations into rrnB strains; the mutants were resistant to
streptomycin. These experiments also effectively rule out the
possibility of compensatory mutations.
Mutation rrs523A3C has been found previously to be asso-
ciated with streptomycin resistance in Chlamydomonas chloro-
plasts (http://www.fandm.edu/departments/biology/databases
/16SMDBexp.html); mutations rrs522C3T, 523A3C, and
526C3T have been observed to be associated with resistance
to streptomycin in clinical isolates of M. tuberculosis (10, 22).
However, with the exception of rrs523A3C (23), experimental
proof for a cause-effect relationship was lacking. Structural
analyses may offer a rationale for some resistance-conferring
mutations (8), but prediction of resistance-conferring muta-
tions is not exhaustive.
Previous investigations on the universally conserved pseudo-
knot structure within the 530 region and resistance-conferring
16S rRNA mutations were limited by a lack of selection-driven
mutational resistance. With respect to the interaction between
nucleotides 505-GGC-507 and 526-CCG-524, these studies
demonstrated that (i) mutations that disrupt pairing between
these bases are deleterious in E. coli, i.e., 505G-526A, 506A-
525C, and 507C-524A; (ii) compensating changes restoring
base pairing restored growth, i.e., 505U-526A, 506A-525U, and
507U-524A; and (iii) certain mild perturbations creating G/U
wobble base pairs are compatible with 16S rRNA function and
confer resistance to streptomycin, i.e., 506G-525U and 507U-
524G (31). Although these landmark studies clearly estab-
lished that mild perturbations within the pseudoknot structure
can lead to streptomycin resistance, those mutations investi-
gated, e.g., rrs507C3T and 525C3T, had to be chosen at will
and bear little relationship to selection-derived mutations
within this structure, i.e., 524G3C and 526C3T. The possi-
bility of investigating selection-driven mutational alterations
allows one to define and characterize those rRNA mutations
which confer a resistant phenotype while simultaneously re-
specting the structural and functional confinements of the ri-
bosome.
One of the most frequent mutations isolated in our work
(rrs524G3C) so far has neither been investigated in geneti-
cally engineered mutants nor has it been observed in in vitro-
selected mutants or in clinical isolates. The absence of rrs524C
mutants in clinical isolates of Mycobacterium tuberculosis most
likely is due to its streptomycin-dependent phenotype. As dem-
onstrated by genetic exchange experiments, the 524C mutation
confers high-level streptomycin resistance. The 524G3C al-
teration is particularly interesting, as it dramatically weakens
the proposed pseudoknot structure between bases 505-GGC-
507 and 526-CCG-524. As discussed above, perturbations of
this pseudoknot structure have been shown to severely impair
growth, which could be restored partially by compensatory
mutations of nucleotides involved in base pairing (31). These
effects have been investigated in mutants with a 525C3T or
507C3T alteration, as these mutations allow wobble base pair-
ing between the respective nucleotides, i.e., 505-GGC-507–
526-CUG-524 and 505-GGU-507–526-CCG-524, respectively.
While our data are in accordance with the view that creation of
a G-U wobble base pair within the pseudoknot structure is
compatible with rRNA function and confers resistance to
streptomycin (as exemplified by the mutation 526C3T), either
the isolation of mutation 524G3C questions the postulate of
a strict base pairing requirement within the pseudoknot struc-
ture for ribosome function (31) or streptomycin induces a
distortion that compensates for the perturbation of the base
pairing within the pseudoknot.
Streptomycin is an antibiotic which causes misreading of the
genetic code by stabilizing the ribosomal ambiguity state, a
conformation in which the aminoacyl-tRNA binding site of the
ribosome has high affinity even to noncognate tRNAs. Strep-
tomycin resistance mutations in rpsL often lead to hyperaccu-
rate but slower ribosomes. While a weak hyperaccuracy results
in streptomycin resistance, a strong hyperaccuracy causes
streptomycin dependence. Mutations causing streptomycin de-
pendence have been found to map in rpsL but also in rrs (16).
In mutant rrs524C the ribosome most likely is trapped in the
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restrictive state unless streptomycin suppresses this mutational
effect (8).
The approach taken in this work, i.e., the generation of a
nonpathogenic single rRNA allelic eubacterium carrying a
multitude of stably integrated rpsL genes, allows selection of
streptomycin resistance-conferring mutations in the 16S rRNA
gene. E. coli is the model organism for eubacteria in general
and for investigation of ribosome structure in particular. How-
ever, the establishment of additional model systems, such as
the single rRNA allelic M. smegmatis, a gram-positive micro-
organism, will help to elucidate common principles in ribo-
some action and ribosome-drug interaction. In addition, gram-
positive and gram-negative bacteria differ with respect to
susceptibility to drugs targeting the bacterial ribosome, e.g.,
oxazolidinones (14). The availability of a suitable gram-posi-
tive microorganism will extend our possibilities to study struc-
ture-function relationships of rRNAs.
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